Premier Biomedical, Inc.

BIEI

US74048K2033

Specialty Chemicals

Market Closed - OTC Markets Other stock markets 15:45:26 2024-06-26 EDT			5-day change	1st Jan Change
0.00075 ^USD	-11.76%		-11.11%	-11.11%

03-07	Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology Officer	CI
2022	Nova-Graphene Ballistics, Inc. Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology	CI

Premier Biomedical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019

November 14, 2019 at 05:12 pm

Premier Biomedical, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was USD 3,465 compared to USD 8,225 a year ago. Operating loss was USD 64,554 compared to USD 81,333 a year ago. Net loss was USD 181,634 compared to USD 363,535 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.11 a year ago. For the nine months, sales was USD 12,975 compared to USD 30,709 a year ago. Operating loss was USD 219,688 compared to USD 230,702 a year ago. Net loss was USD 340,171 compared to net income of USD 102,783 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to basic earnings per share from continuing operations of USD 0.03 a year ago.

Latest news about Premier Biomedical, Inc.

Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology Officer	03-07	CI
Nova-Graphene Ballistics, Inc. Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology	22-12-20	CI
Itaú Unibanco S A : Brazilian billionaire Lemann leads initiative to build COVID-19 vaccine factory	20-08-07	RE
William A. Hartman Resigns as Chief Executive Officer of Premier Biomedical, Inc	20-06-01	CI
Heidi H. Carl Resigns as Chief Financial Officer of Premier Biomedical, Inc	20-06-01	CI
Premier Biomedical, Inc. Announces Executive Changes	20-06-01	CI
Premier Biomedical, Inc. Appoints David Caplan to the Board of Directors	20-06-01	CI
Premier Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-05-15	CI
Premier Biomedical, Inc. Announces Resignation of Mitchell Felder as Chairman and Member of Board of Directors	20-05-07	CI
Premier Biomedical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-14	CI
Premier Biomedical, Inc. announced that it has received $0.025 million in funding from Green Coast Capital International S.A.	19-10-02	CI
Premier Biomedical, Inc. announced that it expects to receive $5 million in funding from Green Coast Capital International S.A.	19-09-25	CI
Premier Biomedical, Inc. announced that it has received $0.043 million in funding from PowerUp Lending Group, Ltd.	19-08-15	CI
Premier Biomedical, Inc. announced that it expects to receive $0.043 million in funding from PowerUp Lending Group, Ltd.	19-08-14	CI
Premier Biomedical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-14	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	19-08-06	CI
Premier Biomedical, Inc. Announces Joint Venture with New Earth Development Corporation, Rushnet, Inc., and XYZ Hemp, Inc	19-08-06	CI
Premier Biomedical, Inc. announced that it expects to receive $0.038 million in funding from PowerUp Lending Group, Ltd.	19-08-01	CI
Premier Biomedical, Inc. Announces Signing of an Agreement Forming a Joint Venture with New Earth Development Corporation, RushNet, Inc., and XYZ Hemp, Inc	19-07-29	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	19-06-11	CI
Premier Biomedical, Inc. announced that it expects to receive $0.038 million in funding from PowerUp Lending Group, Ltd.	19-06-06	CI
Premier Biomedical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-15	CI
Premier Biomedical, Inc. announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	19-04-22	CI
Premier Biomedical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-15	CI
Premier Biomedical, Inc. announced that it has received $0.068 million in funding from PowerUp Lending Group, Ltd.	19-03-27	CI

Chart Premier Biomedical, Inc.

Duration

Period

More charts

Company Profile

Premier Graphene, Inc. is a global advanced materials firm with a focus on research, production and marketing of eco-friendly graphene. The Companyâs graphene and novel additive formulations are integrated into the production process of other products. The Company is engaged in supplying large-scale industrial quantities. Its proprietary graphene blends and formulations target specific product enhancements sought by manufacturers.

Sector

Specialty Chemicals

More about the company

Sector Other Specialty Chemicals

	1st Jan change	Capi.
PREMIER BIOMEDICAL, INC.	-11.11%	824K
ECOLAB INC.	+21.33%	68.72B
SIKA AG	-5.30%	46.48B
GIVAUDAN SA	+24.54%	44.63B
FUJIFILM HOLDINGS CORPORATION	+32.42%	28.07B
EMS-CHEMIE HOLDING AG	+8.22%	19.25B
SYMRISE AG	+15.47%	17.26B
CELANESE CORPORATION	-10.88%	15.12B
POSCO FUTURE M CO., LTD.	-29.11%	14.16B
NITTO DENKO CORPORATION	+20.57%	11.21B

Other Specialty Chemicals